Hemab Therapeutics Holdings, Inc. COAG
Set alert
41.18 USD -0.27 -0.65%
At close · Nov 2
41.18 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
39.96 Day range 42.91
23.00 52-week range 55.42
- YTD
- +21.12%
- 1 year
- +21.12%
- Open
- 41.67
- Prev close
- 41.45
- Mkt cap
- 1.92B
- Vol
- 343.88K
- Avg vol
- 459.12K
- EPS
- -4.31
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 39.96
- High
- 42.91
- Forward P/E
- -16.17
- Beta
- 0.00
- Short ratio
- 5.27
- Inst. own
- 92.52%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 16, 2026
- 50-d avg
- 37.90
- 200-d avg
- 36.78
- 1y target
- 62.67
5D chart
Signals (104)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | Nov 2, 9:30 AM | 16 hours ago |
| SMA: Bullish | Oct 30, 3:45 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:40 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:35 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:30 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:20 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 3:15 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:55 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:45 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:20 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:05 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 12:50 PM | 3 days ago |
| RSI: Overbought | Oct 30, 12:20 PM | 3 days ago |
| SMA: Bullish | Oct 30, 11:15 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:10 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 10:35 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:30 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:30 AM | 3 days ago |
Newest 20 of 104.
Analyst view
Consensus: none
Price target (mean) 62.67 +52.2% upside
Now 41.18
- Target (low)
- 58.00
- Target (mean)
- 62.67
- Target (high)
- 70.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.51529 | -0.55 – -0.41 | 0.00 | 0.0% | 0 | 0.0% | 5 |
| Next quarter | -0.56978 | -0.62 – -0.50 | 0.00 | 0.0% | 0 | 0.0% | 5 |
| Current year | -3.11 | -3.23 – -2.77 | 0.00 | 0.0% | 0 | 0.0% | 5 |
| Next year | -2.55 | -2.81 – -2.30 | -3.11 | +18.1% | 0 | 0.0% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 15, 2026 | JP Morgan | Initiated | — | Overweight |
| Oct 12, 2026 | Rodman & Renshaw | Initiated | — | Buy |
| Aug 12, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Aug 11, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 13, 2026 | Jefferies | Maintained | Buy | Buy |
| Jul 13, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Jul 13, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 26, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 17, 2026 | HC Wainwright & Co. | Initiated | — | Buy |
| May 26, 2026 | Wedbush | Initiated | — | Outperform |
| May 26, 2026 | Jefferies | Initiated | — | Buy |
| May 26, 2026 | Evercore ISI Group | Initiated | — | Outperform |
| May 26, 2026 | Goldman Sachs | Initiated | — | Buy |